How to Help Your Patients Find Montelukast In Stock: A Provider's Guide

If your phone lines are being tied up by patients who can't fill their montelukast prescriptions, you're not alone. Despite montelukast being one of the most widely available generic medications in the U.S., localized pharmacy stock gaps — especially for pediatric formulations — continue to affect patients nationwide. This guide gives your practice a practical workflow for handling these calls efficiently and helping patients get the medication they need.

Why Patients Are Calling About Montelukast Availability

Montelukast is not in a declared national FDA shortage. However, patients frequently encounter localized stock issues for several reasons:

Seasonal demand spikes during spring and fall allergy seasons increase prescription volumes faster than pharmacy reorder cycles.

Pediatric formulations (4 mg granules, 4 mg/5 mg chewables) are manufactured by fewer companies, making them more vulnerable to supply gaps.

Small pharmacies serving high-demand populations may run out before their next delivery.

The good news: the medication is almost always findable within the same day, given the right approach. Your goal is to direct patients to the right resources quickly so your staff isn't spending hours on hold with pharmacies.

Recommended Practice Workflow for Montelukast Fill Issues

Step 1: Triage the Call

When a patient calls about a fill problem, your front office should first determine:

Is this a shortage/stock issue or an insurance/prior authorization issue?

How many days of medication does the patient have left?

Is the patient using montelukast for asthma, allergies, or both?

Is this the adult 10 mg tablet, or a pediatric formulation?

Step 2: Direct to medfinder for Pharmacy Searching

Rather than having your MA or front desk staff call pharmacies, direct patients to medfinder. medfinder contacts pharmacies near the patient to find which ones can fill the prescription, then delivers results by text. This removes the burden from your staff while still rapidly resolving the patient's problem.

You can include medfinder.com in your patient-facing communication as a resource for medication access issues — it covers all medications, not just montelukast.

Step 3: Know When to Call In a New Prescription

If a patient finds a pharmacy with stock but their original prescription was sent elsewhere, you'll need to send a new e-prescription. To reduce the friction here, train staff on the fastest path:

Most pharmacies can accept an electronic transfer from the original pharmacy — they initiate this on their end and your team does not need to be involved.

If the original prescription has no refills remaining, have a standing protocol for your staff to call in or send a new e-prescription for chronic maintenance medications like montelukast, with clinician approval.

Step 4: Bridge Therapy for Patients Who Can't Find It

If a patient with asthma will be without montelukast for more than 2–3 days, consider:

Ensure they have a rescue inhaler (albuterol MDI) available and know when to use it.

For mild persistent asthma: Consider a short course of low-dose ICS (e.g., budesonide inhaler) as bridge while locating montelukast.

For allergic rhinitis: Recommend OTC fluticasone nasal spray (Flonase) or loratadine/cetirizine as short-term alternatives. These are generally more effective than montelukast for nasal symptoms anyway.

Proactive Patient Education to Reduce Supply Calls

You can reduce the number of these calls substantially by building a few proactive steps into your standard prescribing workflow:

Default to 90-day supplies when prescribing montelukast for chronic asthma or perennial allergies. This is lower cost for patients, reduces pharmacy trips, and builds in a supply buffer.

Recommend mail-order pharmacies for patients using montelukast year-round. Express Scripts, CVS Caremark, and Amazon Pharmacy all stock the 10 mg tablet reliably.

Counsel parents of young children on calling ahead before pickup when they have the 4 mg granule or chewable formulation, especially during allergy season.

Documenting Shortage-Related Prescription Changes

When you prescribe an alternative medication due to a supply issue, document the clinical reasoning in the chart — including that the change was temporary pending montelukast availability, if that's the plan. This avoids confusion on future visits and ensures continuity of care. If you switch permanently (e.g., to ICS for better asthma control), update the problem list accordingly.

For more clinical context on alternative therapy selection, see our provider shortage guide for montelukast. To refer patients to a pharmacy search service, visit medfinder for providers.